The North American sleep-wake disorder market is estimated to grow at a CAGR of 5.9% during the forecast period. The growth of the sleep-wake disorder market in North America is attributed to the well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, the aging population of the US was around 52.3 million and Canada was around 6 million in 2018. The geriatric population is more prone to sleep-wake disorders. In addition, the presence of major market players, especially in the US including ResMed Inc., Neurocrine Biosciences, Inc., and others further supports the growth of the sleep-wake disorder market in the region during the forecast period.

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.

Some of the players operating in the North American sleep-wake disorder market include Acorda Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., Somnarus Inc., ResMed Inc., and others. In January 2018, Resmed introduced Mobi which is a portable oxygen concentrator (POC). In May 2017, Resmed launched AirTouch F20 full face mask with UltraSoft memory for comfortable therapy of the patients. In January 2017, the company received FDA approval for AirMini, one of the smallest CPAP machines.

In June 2017, Somnarus, Inc. introduced a new disposable, wearable patch for the effective detection of sleep apnea and other related diseases. The development of novel drugs for the treatment of sleep apnea enables the company to generate revenue and growth of the company.

Research Methodology

The market study of the North American sleep-wake disorder market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for hospitals, sleep disorder device manufacturers, drug manufacturers, physicians, senior care centers, nursing centers, research organizations, investment companies, government organizations, regulatory authorities, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of the market size and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions. 

Market Segmentation

1. North American Sleep-Wake Disorder Market Research and Analysis by Type
2. North American Sleep-Wake Disorder Market Research and Analysis by Treatment

The Report Covers

• Comprehensive research methodology of the North American Sleep-Wake Disorder Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American Sleep-Wake Disorder Market.
• Insights about market determinants which are stimulating the North American Sleep-Wake Disorder Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.